See other companies on Welcome to the Jungle
AKASA
AI-powered automation for the healthcare revenue cycle
- 101-200 employees
- Healthcare
- B2B
- Artificial Intelligence
- Machine Learning
- SaaS
- Automation
- The East Side, South San Francisco, CA
Jump to section
Company mission
To enable human health by building the future of healthcare with AI.
Our take
The US healthcare system is both financially and operationally complex, costing patients and providers an estimated $500B annually in medical billing and insurance administrative expenses. AKASA, formerly Alpha Health, addresses this issue with its Unified Automation™ technology, designed to streamline revenue cycle operations and ease the healthcare burden.
AKASA's approach combines human expertise with AI-driven automation. Its machine-learning tools are supported by revenue cycle specialists who handle complex cases and refine the algorithms. This blend of human and machine intelligence could reshape the healthcare industry.
If successful, AKASA's model could serve as a blueprint for other sectors, demonstrating how automation and human oversight can work together to solve complex operational challenges.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Employer contribution to Health Savings Accounts (HSA)
- Expansive coverage for health, dental, and vision
- Generous parent leave policy
- Full employee coverage for life insurance
- Unlimited paid time off (PTO)
- 401(K) plan
- Company-paid holidays
Company values
- Lead with empathy: We embrace a spirit of generosity, kindness, and inclusivity
- Commit to excellence: We hold ourselves, our work, and our culture to high standard
- Empower yourself & others: We act with autonomy and authenticity, while allowing others to do the same
- Be brave: We shoot for the moon with our ideas and challenge the status quo
- Build trust: We deliver on our promises to each other and our clients
- Play the team: We know that we're better when we work together as one team and support each other
Funding (last 2 of 4 rounds)
Jun 2024
$120m
SERIES C
Mar 2021
$60m
SERIES B
Total funding: $205m
This company has top investors
Leadership
Malinka Walaliyadde
(Co-Founder & CEO)Previously worked at Andreessen Horowitz (a16z), Counsyl and Corning Life Sciences. They have an Engineering degree from Cornell University.
Varun Ganapathi
(Co-Founder & CTO)They have successfully started two AI companies prior to AKASA. One was acquired by Google and the other by Udacity.
Andy Atwal
(Co-Founder & VP of Engineering)Prior to AKASA, they were the founding Software Engineer at Counsyl, a health technology company offering DNA screenings for various diseases.
Ben Beadle-Ryby
(Co-Founder)Previously, they were a Partner at the Advisory Board Company, where they oversaw revenue cycle consulting and technology.